NL8302776A - Moederkoornalkaloiden en werkwijzen voor hun bereiding en toepassing. - Google Patents

Moederkoornalkaloiden en werkwijzen voor hun bereiding en toepassing. Download PDF

Info

Publication number
NL8302776A
NL8302776A NL8302776A NL8302776A NL8302776A NL 8302776 A NL8302776 A NL 8302776A NL 8302776 A NL8302776 A NL 8302776A NL 8302776 A NL8302776 A NL 8302776A NL 8302776 A NL8302776 A NL 8302776A
Authority
NL
Netherlands
Prior art keywords
formula
compounds
acid addition
addition salt
compound
Prior art date
Application number
NL8302776A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8302776A publication Critical patent/NL8302776A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL8302776A 1982-08-09 1983-08-05 Moederkoornalkaloiden en werkwijzen voor hun bereiding en toepassing. NL8302776A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4772/82A CH649998A5 (de) 1982-08-09 1982-08-09 Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
CH477282 1982-08-09

Publications (1)

Publication Number Publication Date
NL8302776A true NL8302776A (nl) 1984-03-01

Family

ID=4282273

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8302776A NL8302776A (nl) 1982-08-09 1983-08-05 Moederkoornalkaloiden en werkwijzen voor hun bereiding en toepassing.

Country Status (23)

Country Link
JP (1) JPS5948480A (fr)
AT (1) AT383125B (fr)
AU (1) AU563736B2 (fr)
BE (1) BE897473A (fr)
CA (1) CA1215972A (fr)
CH (1) CH649998A5 (fr)
DE (1) DE3327705A1 (fr)
DK (1) DK361983A (fr)
ES (1) ES8502992A1 (fr)
FI (1) FI73679C (fr)
FR (1) FR2531433B1 (fr)
GB (1) GB2125041B (fr)
GR (1) GR78923B (fr)
HU (1) HU187600B (fr)
IL (1) IL69450A (fr)
IT (1) IT1168961B (fr)
MY (1) MY8700166A (fr)
NL (1) NL8302776A (fr)
NZ (1) NZ205181A (fr)
PH (1) PH20385A (fr)
PT (1) PT77168B (fr)
SE (1) SE8304315L (fr)
ZA (1) ZA835850B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2589734B1 (fr) * 1985-11-13 1988-09-02 Roussel Uclaf Utilisation de derives de l'ergoline a l'obtention d'un medicament a visee geriatrique
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
DE3913756A1 (de) * 1989-04-21 1990-10-25 Schering Ag 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity

Also Published As

Publication number Publication date
SE8304315L (sv) 1984-02-10
GB2125041A (en) 1984-02-29
PT77168B (en) 1986-03-27
DE3327705A1 (de) 1984-02-09
ES524815A0 (es) 1985-02-01
GR78923B (fr) 1984-10-02
AT383125B (de) 1987-05-25
PT77168A (en) 1983-09-01
IL69450A0 (en) 1983-11-30
MY8700166A (en) 1987-12-31
GB2125041B (en) 1986-04-23
SE8304315D0 (sv) 1983-08-08
ES8502992A1 (es) 1985-02-01
FI832789A (fi) 1984-02-10
FI73679B (fi) 1987-07-31
BE897473A (fr) 1984-02-06
AU563736B2 (en) 1987-07-23
NZ205181A (en) 1986-07-11
DK361983D0 (da) 1983-08-08
HU187600B (en) 1986-01-28
CH649998A5 (de) 1985-06-28
FR2531433A1 (fr) 1984-02-10
PH20385A (en) 1986-12-08
IT1168961B (it) 1987-05-20
IT8322490A0 (it) 1983-08-09
ZA835850B (en) 1985-03-27
DK361983A (da) 1984-02-10
CA1215972A (fr) 1986-12-30
JPS5948480A (ja) 1984-03-19
GB8321222D0 (en) 1983-09-07
ATA286383A (de) 1986-10-15
AU1767283A (en) 1984-02-16
FR2531433B1 (fr) 1985-10-18
FI73679C (fi) 1987-11-09
FI832789A0 (fi) 1983-08-02
IL69450A (en) 1986-10-31

Similar Documents

Publication Publication Date Title
US5366997A (en) Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
EP0482939A1 (fr) Dérive d'isoquinolinone
EP0579681B1 (fr) Monohydrate d'hydrochlorure de tiagabine cristalline, sa preparation et son utilisation
EP0148167B1 (fr) Nouveaux dérivés de la quinoléine, leur procédé de préparation et les compositions pharmaceutiques les renfermant
AU619766B2 (en) 2,2-dimethylchromene derivatives, process for their preparation and pharmaceutical compositions in which they are present
EP0343050A1 (fr) Dérivés de phényl-6 pipérazinyl-alkyl-3 1H,3H-pyrimidinedione-2,4, leur préparation et leur application en thérapeutique
EP0161599A2 (fr) Dérivés de benzazépine, médicaments contenant les composés et procédé pour leur préparation
NL8302776A (nl) Moederkoornalkaloiden en werkwijzen voor hun bereiding en toepassing.
CA2214744C (fr) Derives de 3-(bis-phenylmethylene substitue) oxindole
HUT71132A (en) Bis-aryl-carbinol derivatives, pharmaceutical compositions containing them and process for producing
EP0591027A1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique
LU85423A1 (fr) Nouveaux derives de la 1,4-dihydropyridine,leur preparation et leur utilisation comme medicaments
JP2690749B2 (ja) ベンズイミダゾール誘導体、その製造方法およびその医薬への応用
EP1330456B1 (fr) Sels de quino[4,3,2-kl]acridinium n8,n13-disubstitues utilises comme agents therapeutiques
AU618007B2 (en) 2,2-dimethylchroman-3-ol derivatives, process for their preparation and pharmaceutical compositions in which they are present
EP0180833B1 (fr) Dérivés de la 4-oxopyrido[2,3-d]pyrimidine, procédé pour leur préparation et médicaments les contenant
KR100375112B1 (ko) 퀴녹살린디온
JPH0764844B2 (ja) ピリダジノピロロイソキノリン誘導体
SK34893A3 (en) Indenindole derivatives, process for their preparation and their pharmaceutical compositions
CS199258B2 (en) Process for preparing new antibiotic compounds of rifamycine-s,substituted in 3 position by aliphatic substituted aminogroup
HU189844B (en) Process for preparing pyrazolo/1,5-a/pyridine derivatives
CN117545742A (zh) 嘧啶类化合物、包含其的药物组合物、其制备方法及其用途
EP0183002B1 (fr) Dérivé de sel de 3-hydroxy-5-(hydroxyméthyl)-2-méthyl-isonicobinaldéhyde phosphate avec activité pharmaceutique
CH657366A5 (en) Ergot alkaloids, their preparation and use
EP0012347A1 (fr) 7,8,9,10-Tétrahydrothiéno(3,2-e)pyrido(4,3-b)indoles, procédé pour leur préparation et des médicaments les contenant

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed